YD Bio Ltd YDES
Set alert
5.94 USD +0.07 +1.19%
At close · Oct 30
5.94 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
5.67 Day range 6.10
1.70 52-week range 15.72
- YTD
- -51.27%
- 1 year
- -46.53%
- Open
- 5.99
- Prev close
- 5.87
- Mkt cap
- 420.74M
- Vol
- 47.35K
- Avg vol
- 304.18K
- EPS
- -0.04
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 5.67
- High
- 6.10
- Forward P/E
- 0.00
- Beta
- 0.16
- Short ratio
- 0.77
- Inst. own
- 0.35%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 17.26
- 200-d avg
- 17.26
- 1y target
- 0.00
3M chart
Signals (15)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 27, 2026 | 5 days ago |
| SMA: Bullish | Oct 23, 2026 | 1 week ago |
| SMA: Bearish | Oct 22, 2026 | 1 week ago |
| SMA: Bearish | Oct 22, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 12, 2026 | 2 weeks ago |
| RSI: Overbought | Sep 28, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 25, 2026 | 1 month ago |
| SMA: Bullish | Sep 24, 2026 | 1 month ago |
| SMA: Bullish | Sep 23, 2026 | 1 month ago |
| SMA: Bearish | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 17, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| RSI: Overbought | Aug 18, 2026 | 2 months ago |
| SMA: Bullish | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
Key statistics
- Market cap
- 933.70M
- Enterprise value
- 19.67M
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 1829.50
- Price / book
- 2.90
- EPS (TTM)
- -0.02
- Beta
- 0.16
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -276.58%
- Revenue (TTM)
- 510.36K
- Revenue growth
- 95.60%
- Free cash flow
- -3.88M
- Total cash
- 3.13M
- Total debt
- 22.27K
- Return on equity
- -42.69%
- Shares outstanding
- 70.52M
- Short % of float
- 0.52%
- 50-day average
- 17.26
- 200-day average
- 17.26
Analyst view
Consensus: none
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
YDES Revenue — quarterly 510.36K
YDES Net income — quarterly 1.31M
YDES EPS — quarterly 0.09
About YD Bio Ltd
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Taiwan
- Website
- ydesgroup.com
News
- YD Bio (NASDAQ:YDES) Stock Crosses Above 200-Day Moving Average – Here’s What Happened
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- YD Bio and EG BioMed Partner with JoiiUp to Launch AI-Driven Cancer Risk Assessment for Corporate Wellness Programs
- YD Bio Limited (NASDAQ:YDES) Sees Significant Increase in Short Interest
- 12 Health Care Stocks Moving In Friday's Intraday Session
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- YD Bio and EG BioMed Launch AI-Based 10-Cancer Risk Factor Assessment
- YD Bio (NASDAQ:YDES) Shares Down 4.4% – Here’s Why
- Kodiak Sciences, AMC Entertainment, Agenus And Other Big Stocks Moving Higher On Monday
- 12 Health Care Stocks Moving In Monday's Intraday Session
Your note
Sign in to keep a note on YDES — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Cerity Partners LLC | 0.05% | 32,406 | 429.06K | Sep 29, 2025 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index ETF | 0.03% | 20,862 | 276.21K | Sep 29, 2025 |